Jurdy's Blog on Personal Injuries
Monheit Law | Blog Home | By Month | Articles | Category Index |
Permax | Adderall | Crestor | Bextra | Vioxx | Strattera
| Injured by a Dangerous Pharmaceutical Product?
Contact Monheit Law. Free Inquiry.
|
Monheit Law : Blog Home : 2005-02-25 : Article

Pfizer Criticized for Inadequate Celebrex Safety Data

Pfizer was criticized by members of a Food and Drug Administration advisory committee for having inadequate long-term safety data on its blockbuster arthritis drug Celebrex.

After Merck recalled its blockbuster and rival COX-2 inhibitor Vioxx from the market last September, the safety of Pfizer?s COX-2 drugs Celebrex and Bextra were called into question. A Merck sponsored long-term study had discovered an increased risk of heart attacks and strokes in Vioxx users.